Inventor
STEFANIDIS DIMITRIOS
US30 patents
⚠️ This page may combine multiple inventors who share the name “STEFANIDIS DIMITRIOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
8 patentsUS10071985B2Sep 11, 2018
Therapeutic compounds
GILEAD SCIENCES INC43 citations97
US10654827B2May 19, 2020
Therapeutic compounds
GILEAD SCIENCES INC24 citations93
US9469613B2Oct 18, 2016
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
GILEAD SCIENCES INC15 citations91
US11944611B2Apr 2, 2024
Capsid inhibitors for the treatment of HIV
GILEAD SCIENCES INC11 citations78
US11993583B2May 28, 2024
Therapeutic compounds
GILEAD SCIENCES INC3 citations75
US11707479B2Jul 25, 2023
Combination formulation of two antiviral compounds
GILEAD SCIENCES INC1 citations71
US9809559B2Nov 7, 2017
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
GILEAD SCIENCES INC3 citations71
US11338007B2May 24, 2022
Combination formulation of three antiviral compounds
GILEAD SCIENCES INC0 citations55
GILEAD PHARMASSET LLC
7 patentsUS8889159B2Nov 18, 2014
Compositions and methods for treating hepatitis C virus
GILEAD PHARMASSET LLC114 citations96
US9549941B2Jan 24, 2017
Compositions and methods for treating hepatitis C virus
GILEAD PHARMASSET LLC39 citations91
US10086011B2Oct 2, 2018
Combination formulation of two antiviral compounds
GILEAD PHARMASSET LLC8 citations82
US9757406B2Sep 12, 2017
Combination formulation of two antiviral compounds
GILEAD PHARMASSET LLC9 citations82
US11116783B2Sep 14, 2021
Combination formulation of two antiviral compounds
GILEAD PHARMASSET LLC2 citations71
US10912814B2Feb 9, 2021
Combination formulation of three antiviral compounds
GILEAD PHARMASSET LLC0 citations55
US10039779B2Aug 7, 2018
Combination formulation of two antiviral compounds
GILEAD PHARMASSET LLC1 citations49
GILEAD CONNECTICUT INC
5 patentsUS9382256B2Jul 5, 2016
Formulation of Syk inhibitors
GILEAD CONNECTICUT INC17 citations90
US9949932B2Apr 24, 2018
Formulation of syk inhibitors
GILEAD CONNECTICUT INC8 citations82
US9918939B2Mar 20, 2018
Formulation of Syk inhibitors
GILEAD CONNECTICUT INC8 citations82
US10266539B2Apr 23, 2019
Polymorph of Syk inhibitors
GILEAD CONNECTICUT INC7 citations80
US9657023B2May 23, 2017
Polymorph of Syk inhibitors
GILEAD CONNECTICUT INC12 citations80